Hendrik Van Poppel, MD, PhD, from KU Leuven, Leuven, Belgium, discusses the potential impact of multi-parametric MRI (mpMRI) in patients with prostate cancer at the European Association of Urology (EAU) conference 2017 in London, UK. Imaging of prostate cancer typically involves the use of transrectal ultrasounds, however, recently, mpMRI has come to the forefront. mpMRI is currently only used in the diagnosis of patients who have had a negative biopsy. Prof. Van Poppel explains that there is potential for using mpMRI to monitor patients with low-risk prostate cancer, where active treatment, such as radiotherapy or prostatectomy, is not proposed. He states that this is an important development in prostate cancer imaging that has been highlighted at this year’s congress.